Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

10.3322/canjclin.55.2.74

10.1007/s00345-004-0466-0

10.1056/NEJM199609193351207

10.1016/S0094-0143(03)00056-9

Fisher RI, 2000, Cancer J Sci Am, 6, S55

10.1200/JCO.2005.03.206

Motzer RJ, 2000, J Clin Oncol, 18, 2972, 10.1200/JCO.2000.18.16.2972

10.1056/NEJM199804303381805

10.1200/JCO.2003.02.122

10.1200/JCO.2005.02.2574

10.1001/jama.295.21.2516

Abrams TJ, 2003, Mol Cancer Ther, 2, 471, 10.4161/cbt.2.5.446

Mendel DB, 2003, Clin Cancer Res, 9, 327

10.1182/blood-2002-07-2307

10.1038/ng0594-85

10.1073/pnas.93.20.10595

10.1038/20459

10.1097/01.ju.0000074870.54671.98

10.1056/NEJMoa021491

10.1200/JCO.20.1.289

10.1093/jnci/92.3.205

Cella DF, 1993, J Clin Oncol, 11, 570, 10.1200/JCO.1993.11.3.570

Cella D, 2006, J Support Oncol, 4, 191

10.1200/JCO.2005.05.179

Mantel N, 1966, Cancer Chemother Rep, 50, 163

Cox DR, Oakes D. Analysis of survival data. New York: Chapman and Hall, 1990.

Doing data analysis with the multilevel model for change. In: Singer JD, Willett JB. Applied longitudinal data analysis: modeling change and event occurrence. New York: Oxford University Press, 2003:75-137.

10.2307/2336502

10.1177/0163278705275341

10.1016/S0022-5347(05)67889-5

Coppin C, 2005, Cochrane Database Syst Rev, 1, CD001425

10.1016/S0140-6736(98)03544-2

Pyrhonen S, 1999, J Clin Oncol, 17, 2859, 10.1200/JCO.1999.17.9.2859

Negrier S, 2005, Proc Am Soc Clin Oncol, 23, 380s

Fyfe GA, 1996, J Clin Oncol, 14, 2410, 10.1200/JCO.1996.14.8.2410

10.1002/(SICI)1097-0142(19980815)83:4<797::AID-CNCR25>3.0.CO;2-M

Escudier B, 2005, Proc Am Soc Clin Oncol, 24, 380s